Pasireotide (aspartate) (trifluoroacetate salt)

Pasireotide (aspartate) (trifluoroacetate salt)
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
Cay24092-1 1 mg -

6 - 10 Werktage*

212,00 €
Cay24092-5 5 mg -

6 - 10 Werktage*

839,00 €
Cay24092-10 10 mg -

6 - 10 Werktage*

1.362,00 €
 
Pasireotide is a somatostatin receptor (SSTR) agonist that binds selectively to SST1, SST2, SST3,... mehr
Produktinformationen "Pasireotide (aspartate) (trifluoroacetate salt)"
Pasireotide is a somatostatin receptor (SSTR) agonist that binds selectively to SST1, SST2, SST3, and SST5 over SST4 (IC50s = 9.3, 1, 1.5, 0.16, and >100 nM, respectively, for human recombinant receptors). It dose-dependently inhibits growth hormone release stimulated by growth hormone-releasing hormone (GHRH) in primary rat anterior pituitary cells and inhibits adrenocorticotropic hormone (ACTH) secretion by some primary human corticotrope adenomas at a concentration of 10 nM. Pasireotide (10 nM) also inhibits ACTH release from and proliferation of mouse AtT20 pituitary corticotrope cells in vitro and inhibits tumor growth of subcutaneously implanted AtT20 cells in vivo in nude mice when administered at a dose of 1.5 µg per day. Pasireotide (0.03 mg/kg) decreases plasma ACTH concentrations and tumor size in dogs with ACTH-dependent Cushing's disease. Formulations containing pasireotide have been used in the treatment of acromegaly and Cushing's disease.Formal Name: cyclo[(2R)-2-phenylglycyl-D-tryptophyl-L-lysyl-O-(phenylmethyl)-L-tyrosyl-L-phenylalanyl-(4R)-4-[[[(2-aminoethyl)amino]carbonyl]oxy]-L-prolyl], L-aspartate (1:2), trifluoroacetate salt. Synonyms: SOM230. Molecular Formula: C58H66N10O9 . 2C4H7NO4 . XCF3COOH. Formula Weight: 1313.4. Purity: >95%. Formulation: (Request formulation change), A crystalline solid. Solubility: DMF: 33 mg/ml, DMSO: 33 mg/ml, Ethanol: 33 mg/ml, Ethanol:PBS (pH 7.2) (1:3): 0.25 mg/ml. SMILES: O=C([C@H](CC1=CC=CC=C1)N2)N3[C@](C[C@@H](OC(NCCN)=O)C3)([H])C(N[C@H](C4=CC=CC=C4)C(N[C@H](CC5=CNC6=C5C=CC=C6)C(N[C@@H](CCCCN)C(N[C@@H](CC7=CC=C(OCC8=CC=CC=C8)C=C7)C2=O)=O)=O)=O)=O.OC(C[C@H](N)C(O)=O)=O.OC(C[C@H](N)C(O)=O)=O.FC(F)(C(O)=O)F. InChi Code: InChI=1S/C58H66N10O9.2C4H7NO4.C2HF3O2/c59-27-13-12-22-46-52(69)64-47(30-38-23-25-42(26-24-38)76-36-39-16-6-2-7-17-39)53(70)66-49(31-37-14-4-1-5-15-37)57(74)68-35-43(77-58(75)61-29-28-60)33-50(68)55(72)67-51(40-18-8-3-9-19-40)56(73)65-48(54(71)63-46)32-41-34-62-45-21-11-10-20-44(41)45,2*5-2(4(8)9)1-3(6)7,3-2(4,5)1(6)7/h1-11,14-21,23-26,34,43,46-51,62H,12-13,22,27-33,35-36,59-60H2,(H,61,75)(H,63,71)(H,64,69)(H,65,73)(H,66,70)(H,67,72),2*2H,1,5H2,(H,6,7)(H,8,9),(H,6,7)/t43-,46+,47+,48-,49+,50+,51-,2*2-,/m100./s1. InChi Key: LBWKTPKTMIBIDM-DOKMMQMOSA-N.
Schlagworte: SOM230, cyclo[(2R)-2-phenylglycyl-D-tryptophyl-L-lysyl-O-(phenylmethyl)-L-tyrosyl-L-phenylalanyl-(4R)-4-[[[(2-aminoethyl)amino]carbonyl]oxy]-L-prolyl], L-aspartate (1:2), trifluoroacetate salt
Hersteller: Cayman Chemical
Hersteller-Nr: 24092

Eigenschaften

Anwendung: Somatostatin receptor agonist
MW: 1313.4 D
Formel: C58H66N10O9 . 2C4H7NO4 . XCF3COOH
Reinheit: >95%
Format: Crystalline Solid

Datenbank Information

KEGG ID : K04218 | Passende Produkte

Handhabung & Sicherheit

Lagerung: -20°C
Versand: +20°C (International: -20°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Pasireotide (aspartate) (trifluoroacetate salt)"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen